课题基金 / 基金详情

PHARMACOGENETICS OF ANTIDEPRESSANT RESPONSE AND REMISSION: TOWARD GENOTYPE-GUIDED PRESCRIBING IN MAJOR DEPRESSIVE DISORDER

PHARMACOGENETICS OF ANTIDEPRESSANT RESPONSE AND REMISSION: TOWARD GENOTYPE-GUIDED PRESCRIBING IN MAJOR DEPRESSIVE DISORDER
抗抑郁药反应和缓解的药物遗传学：针对重度抑郁症的基因型指导处方
批准号：
nhmrc : 1127700
负责人：
Dr Chad Bousman
金额：
$29.04万
依托单位：
The University of Melbourne
依托单位国家：
澳大利亚
项目类别：
Career Development Fellowships
财政年份：
2017
资助国家：
澳大利亚
项目状态：
已结题
起止时间：
2017-01-01 至 2020-12-31
来源：
https://researchdata.edu.au/pharmacogenetics-antidepressant-response-depressive-disorder/948043
关键词：
PHARMACOGENETICSANTIDEPRESSANTRESPONSEREMISSIONTOWARD

项目摘要

项目成果

Dr Chad Bousman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A “one-size fits all” approach to antidepressant pharmacotherapy in depression is suboptimal. Current technology and scientific data support the transition to a personalised approach to antidepressant pharmacotherapy. My research will (1) develop and test genetic based algorithms for their ability to predict antidepressant response and remission and (2) evaluate the clinical validity and utility of currently available algorithms in clinical practice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Kava for the Treatment of Generalized Anxiety Disorder: A 16-Week Double-Blind RCT
  • 批准号：
    nhmrc : 1063383
  • 项目类别：
    Project Grants
  • 资助金额：
    $45.38万
  • 财政年份：
    2014
  • 负责人：
    Dr Chad Bousman
  • 依托单位：
    The University of Melbourne
The Efficacy of Adjunctive S-Adenosyl Methionine (SAMe) versus a Combination Nutraceutical in Clinical Depression: A Double-Blind, Randomised, Placebo-Controlled Trial
  • 批准号：
    nhmrc : 1048222
  • 项目类别：
    Project Grants
  • 资助金额：
    $53.36万
  • 财政年份：
    2013
  • 负责人：
    Dr Chad Bousman
  • 依托单位：
    The University of Melbourne
海外基金